EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effect of preoperative SGLT2 inhibitor use on postoperative acute kidney injury in patients with type 2 diabetes undergoing surgery: A causal inference study using routinely collected data

Einfluss der präoperativen SGLT2-Inhibitor-Anwendung auf postoperative akute Nierenschädigung bei Patient:innen mit Typ-2-Diabetes nach Operation: eine kausale Inferenzstudie mit Routinedaten

Frank M Gao, Kartik Kishore, Dinesh Pandey, Hossein Jahanabadi, Meg Stevens, Ashani Lecamwasam, Leonid Churilov, Elif I Ekinci iD

Diabetes, Obesity and Metabolism · 2026-04 · 28 (4) · 3193-3201

DOI: 10.1111/dom.70509 ↗

Auf einen Blick

Bei 2.499 Patient:innen mit Typ-2-Diabetes war eine präoperative SGLT2i-Anwendung mit seltenerer postoperativer AKI verbunden. Das Risiko war niedriger als ohne SGLT2i.

Fragestellung

Reduziert eine präoperative SGLT2i-Anwendung bei Patient:innen mit Typ-2-Diabetes das Risiko einer postoperativen akuten Nierenschädigung (AKI)?

Methode

Target-Trial-Emulation mit Inverse-Probability-of-Treatment-Weighting; Routinedaten aus einem Zentrum in Australien; Operation unter Allgemeinanästhesie.

Ergebnisse

2.499 Patient:innen: 738 mit und 1.761 ohne präoperative SGLT2i-Anwendung. AKI innerhalb von 7 Tagen: 18,6 % vs. 25,8 %; adjustierte OR 0,71 (95 %-KI 0,56–0,91; p = 0,007).

Schlussfolgerung der Autor:innen

Bei Patient:innen mit Typ-2-Diabetes, die präoperativ SGLT2i verwendeten, war die Wahrscheinlichkeit einer postoperativen akuten Nierenschädigung reduziert.

Kernaussagen

  • AKI innerhalb von 7 Tagen war unter SGLT2i seltener
  • Adjustierte OR 0,71 (95 %-KI 0,56–0,91)
  • Effekte in Subgruppen- und Sensitivitätsanalysen konsistent

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 29.01.2026. Verfasst von Frank M Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Austin Hospital, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Acute Kidney Injury, Sodium-Glucose Transporter 2 Inhibitors, Postoperative Complications. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Melbourne, Australian Government.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To assess whether preoperative sodium‐glucose co‐transporter 2 inhibitor (SGLT2i) use reduces the odds of postoperative acute kidney injury (AKI) in patients with type 2 diabetes undergoing surgery.

Methods

We conducted a target trial emulation using inverse probability of treatment weighting, utilising routinely collected data from a tertiary centre in Australia. Patients with type 2 diabetes were included. We compared patients undergoing surgery under general anaesthesia who were taking SGLT2i preoperatively with patients undergoing surgery who were not taking SGLT2i preoperatively. The primary outcome was postoperative AKI within 7 days of surgery. We estimated the average treatment effect on the treated and calculated adjusted odds ratios (ORs) and standardised risk differences.

Results

We included 2499 patients (738 taking SGLT2i preoperatively and 1761 not taking SGLT2i preoperatively). Over half of patients underwent emergency surgery. Postoperative AKI occurred in 18.6% taking SGLT2i preoperatively and 25.8% not taking SGLT2i preoperatively. Odds of postoperative AKI were significantly lower in those who used SGLT2i preoperatively (adjusted OR 0.71, 95% CI 0.56–0.91, p = 0.007). Effects were consistent across subgroup and sensitivity analyses.

Conclusions

In patients with type 2 diabetes who used SGLT2i preoperatively, its use reduced the odds of postoperative acute kidney injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Acute Kidney InjurySodium-Glucose Transporter 2 InhibitorsPostoperative ComplicationsDiabetic NephropathiesHumansFemaleMaleMiddle AgedAgedPreoperative CareAustralia

Stichwörter der Autor:innen

SGLT2 inhibitorsacute kidney injurysurgerytype 2 diabetes

Substanzen

Sodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Department of Endocrinology, Austin Hospital, Melbourne, Victoria, Australia.
  • Department of Medicine, Austin Health, Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia.
  • Australian Centre for Accelerating Diabetes Innovations, Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia.
  • Data Analytics Research and Evaluation Centre, Austin Hospital, Melbourne, Victoria, Australia.
  • Department of Nephrology, Northern Health, Melbourne, Victoria, Australia.
  • Department of Medicine (RMH), Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia.

ORCID-Profile: Elif I Ekinci

Förderung

  • University of Melbourne
  • Australian Government

Zitieren

APA

Gao, F. M., Kishore, K., Pandey, D., Jahanabadi, H., Stevens, M., Lecamwasam, A., Churilov, L., & Ekinci, E. I. (2026). Effect of preoperative SGLT2 inhibitor use on postoperative acute kidney injury in patients with type 2 diabetes undergoing surgery: A causal inference study using routinely collected data. Diabetes, Obesity and Metabolism, 28(4), 3193-3201. https://doi.org/10.1111/dom.70509

Vancouver

Gao FM, Kishore K, Pandey D, Jahanabadi H, Stevens M, Lecamwasam A, et al. Effect of preoperative SGLT2 inhibitor use on postoperative acute kidney injury in patients with type 2 diabetes undergoing surgery: A causal inference study using routinely collected data. Diabetes, Obesity and Metabolism. 2026;28(4):3193-3201. doi:10.1111/dom.70509

BibTeX
@article{Gao2026,
  author = {Gao, Frank M and Kishore, Kartik and Pandey, Dinesh and Jahanabadi, Hossein and Stevens, Meg and Lecamwasam, Ashani and Churilov, Leonid and Ekinci, Elif I},
  title = {Effect of preoperative SGLT2 inhibitor use on postoperative acute kidney injury in patients with type 2 diabetes undergoing surgery: A causal inference study using routinely collected data},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {4},
  pages = {3193--3201},
  doi = {10.1111/dom.70509}
}
Kostenlos starten →